Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic

Virol J. 2013 Jan 22:10:29. doi: 10.1186/1743-422X-10-29.

Abstract

Background: Cameroon, in west central Africa, has an extraordinary degree of HIV diversity, presenting a major challenge for the development of an effective HIV vaccine. Given the continuing need to closely monitor the emergence of new HIV variants in the country, we analyzed HIV-1 genetic diversity in 59 plasma samples from HIV-infected Cameroonian blood donors. Full length HIV gag and nef sequences were generated and phylogenetic analyses were performed.

Findings: All gag and nef sequences clustered within HIV-1M. Circulating recombinant form CRF02_AG predominated, accounting for 50% of the studied infections, followed by clade G (11%), clade D and CRF37_cpx (4% each), and clades A, F, CRF01_AE and CRF36_cpx (2% each). In addition, 22% of the studied viruses apparently had nef and gag genes from viruses belonging to different clades, with the majority (8/10) having either a nef or gag gene derived from CRF02_AG. Interestingly, five gag sequences (10%) and three (5%) nef sequences were neither obviously recombinant nor easily classifiable into any of the known HIV-1M clades.

Conclusion: This suggests the widespread existence of highly divergent HIV lineages in Cameroon. While the genetic complexity of the Cameroonian HIV-1 epidemic has potentially serious implications for the design of biomedical interventions, detailed analyses of divergent Cameroonian HIV-1M lineages could be crucial for dissecting the earliest evolutionary steps in the emergence of HIV-1M.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Donors
  • Cameroon / epidemiology
  • Cluster Analysis
  • Female
  • Genetic Variation*
  • Genotype
  • HIV Infections / epidemiology*
  • HIV Infections / virology*
  • HIV-1 / classification*
  • HIV-1 / genetics*
  • HIV-1 / isolation & purification
  • Humans
  • Male
  • Middle Aged
  • Molecular Epidemiology
  • Molecular Sequence Data
  • Phylogeny
  • Sequence Analysis, DNA
  • Young Adult
  • gag Gene Products, Human Immunodeficiency Virus / genetics*
  • nef Gene Products, Human Immunodeficiency Virus / genetics*

Substances

  • gag Gene Products, Human Immunodeficiency Virus
  • nef Gene Products, Human Immunodeficiency Virus
  • nef protein, Human immunodeficiency virus 1

Associated data

  • GENBANK/JX244899
  • GENBANK/JX244900
  • GENBANK/JX244901
  • GENBANK/JX244902
  • GENBANK/JX244903
  • GENBANK/JX244904
  • GENBANK/JX244905
  • GENBANK/JX244906
  • GENBANK/JX244907
  • GENBANK/JX244908
  • GENBANK/JX244909
  • GENBANK/JX244910
  • GENBANK/JX244911
  • GENBANK/JX244912
  • GENBANK/JX244913
  • GENBANK/JX244914
  • GENBANK/JX244915
  • GENBANK/JX244916
  • GENBANK/JX244917
  • GENBANK/JX244918
  • GENBANK/JX244919
  • GENBANK/JX244920
  • GENBANK/JX244921
  • GENBANK/JX244922
  • GENBANK/JX244923
  • GENBANK/JX244924
  • GENBANK/JX244925
  • GENBANK/JX244926
  • GENBANK/JX244927
  • GENBANK/JX244928
  • GENBANK/JX244929
  • GENBANK/JX244930
  • GENBANK/JX244931
  • GENBANK/JX244932
  • GENBANK/JX244933
  • GENBANK/JX244934
  • GENBANK/JX244935
  • GENBANK/JX244936
  • GENBANK/JX244937
  • GENBANK/JX244938
  • GENBANK/JX244939
  • GENBANK/JX244940
  • GENBANK/JX244941
  • GENBANK/JX244942
  • GENBANK/JX244943
  • GENBANK/JX244944
  • GENBANK/JX244945
  • GENBANK/JX244946
  • GENBANK/JX244947
  • GENBANK/JX244948
  • GENBANK/JX244949
  • GENBANK/JX244950
  • GENBANK/JX244951
  • GENBANK/JX244952
  • GENBANK/JX244953